Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemiaAndreas Bühler, Thorsten Zenz, Stephan Stilgenbauer
Haematologica|September 3, 2010
Biological diversity and risk-adapted treatment of chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Stephan Stilgenbauer
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2019
Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library ScreensKatarzyna Tomska, Sebastian Scheinost, Thorsten Zenz
Leukemia & Lymphoma|December 17, 2009
More (on) prognostic factors in chronic lymphocytic leukemiaThorsten Zenz, Simone Fulda, Stephan Stilgenbauer
Leukemia Research|August 28, 2009
MDM2 promotor polymorphism and disease characteristics in CLLThorsten Zenz, Axel Benner, Stephan Stilgenbauer
Best Practice & Research. Clinical Haematology|August 21, 2007
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemiaThorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer
The Lancet. Infectious Diseases|November 25, 2006
Sir, I turned much darker!Thorsten Zenz, Julia Aufschild, Bernhard O Boehm
Leukemia & Lymphoma|May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implicationsThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2008
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathwayThorsten Zenz, Axel Benner, Hartmut Döhner, et al.
Blood Reviews|March 26, 2011
Importance of genetics in chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemiaAndreas Bühler, Thorsten Zenz, Stephan Stilgenbauer
Haematologica|September 3, 2010
Biological diversity and risk-adapted treatment of chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Stephan Stilgenbauer
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2019
Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library ScreensKatarzyna Tomska, Sebastian Scheinost, Thorsten Zenz
Leukemia & Lymphoma|December 17, 2009
More (on) prognostic factors in chronic lymphocytic leukemiaThorsten Zenz, Simone Fulda, Stephan Stilgenbauer
Leukemia Research|August 28, 2009
MDM2 promotor polymorphism and disease characteristics in CLLThorsten Zenz, Axel Benner, Stephan Stilgenbauer
Best Practice & Research. Clinical Haematology|August 21, 2007
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemiaThorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer
The Lancet. Infectious Diseases|November 25, 2006
Sir, I turned much darker!Thorsten Zenz, Julia Aufschild, Bernhard O Boehm
Leukemia & Lymphoma|May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implicationsThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2008
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathwayThorsten Zenz, Axel Benner, Hartmut Döhner, et al.
Blood Reviews|March 26, 2011
Importance of genetics in chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Pageof 19